DASATINIB S.K. 20 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

DASATINIB

Mevcut itibaren:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

ATC kodu:

L01XE06

Farmasötik formu:

FILM COATED TABLETS

Kompozisyon:

DASATINIB 20 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

REMEDICA LTD., CYPRUS

Terapötik alanı:

DASATINIB

Terapötik endikasyonlar:

Dasatinib is indicated for the treatment of adult patients with:• newly diagnosed Philadelphia-chromosome-positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase;• chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate;• Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.

Yetkilendirme tarihi:

2023-09-20